TNYA · NASDAQ
Tenaya Therapeutics (TNYA) Stock Price & Fundamentals
Tenaya Therapeutics (TNYA) closed at $328.43 on Oct 9, 2026, down 0.58% from the previous close of $330.36.
Share price, past year
1Y +16.27%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $328.43 |
| Sep 30, 2026 | $323.66 |
| Aug 31, 2026 | $336.44 |
| Jul 31, 2026 | $314.72 |
| Jun 30, 2026 | $297.59 |
| May 29, 2026 | $289.11 |
| Apr 30, 2026 | $300.42 |
| Mar 31, 2026 | $290.18 |
| Feb 27, 2026 | $278.95 |
| Jan 30, 2026 | $268.15 |
| Dec 31, 2025 | $266.81 |
| Nov 28, 2025 | $265.02 |
| Oct 31, 2025 | $278.43 |
Key statistics
- Market cap
- $73.64B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.50
- Revenue (TTM)
- —
- Net income (TTM)
- −$103.12M
- Shares outstanding
- 224.2M
- Dividend yield
- —
- 52-week range
- $254.68 – $344.34
Tenaya Therapeutics's market cap is $73.64B, based on a share price of $328.43 and 224.2M shares outstanding as of Jun 30, 2026.
Financials
Tenaya Therapeutics reported a net loss of $90.60M in fiscal 2025.
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.11M | −$43.39M | −$0.20 |
| Q1 FY2026ended Mar 31, 2026 | $225.00K | −$19.27M | −$0.09 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$23.28M | −$0.14 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$26.86M | −$0.24 |
Company profile
- Name
- Tenaya Therapeutics, Inc.
- Ticker
- TNYA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 171 Oyster Point Blvd., Suite 500, South San Francisco, CA 94080
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001858848
Recent SEC filings
- Aug 5, 2026
- Aug 5, 2026
- Jul 2, 2026
- Jun 29, 2026
- May 29, 2026
- May 6, 2026
- May 6, 2026
- Mar 11, 2026
Frequently asked questions
What is Tenaya Therapeutics's stock price?
Tenaya Therapeutics (TNYA) closed at $328.43 on Oct 9, 2026, down 0.58% from the previous close of $330.36.
What is Tenaya Therapeutics's market cap?
Tenaya Therapeutics's market cap is $73.64B, based on a share price of $328.43 and 224.2M shares outstanding as of Jun 30, 2026.
Does Tenaya Therapeutics pay a dividend?
Tenaya Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Tenaya Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures